Early phase clinical trials

Early phase studies are often designed and implemented without substantive statistical input. The 3+3 maximum tolerated dose finding design being a classic example. This group aims to improve statistical aspects of early phase studies, by bridging the gap between clinical trialists using traditional designs and modern statistical methodologists with many improvements to offer.

We are interested in reaching a consensus within the statistical community of which modern methods should be regarded as standard. We aim to communicate these methods to a wider audience through training and education to increase their use in real-life trials.

Collaborative research enables us to consolidate our knowledge and share expertise. Our research section seeks to undertake collaborative working to promote high quality research by tackling discipline specific issues.

If you would like to join a working group committee or wish to find out more, please email the NIHR Statistics Group.